ResMed Support for Investigator Initiated Trials

ResMed changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with millions of patients remotely monitored every day. Our team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.

As part of our commitment to deliver innovative therapies to patients across the globe, ResMed believes in the need to support ethical, independent clinical research, conducted by qualified third-party investigators. Investigator Initiated Trials (IITs) serve as an important complement to ResMed-sponsored research, to help better understand the benefits and risks of our therapies, as well as to explore new opportunities to address unmet medical needs. Such clinical research must be aimed at addressing meaningful scientific and/or clinical objectives, supported by valid study designs in which the safety, welfare and privacy rights of patients are of paramount importance.

Like many other health care-focused companies, ResMed supports the funding of Investigator initiated trials through a well-defined process with robust governance measures. Preference will be given to programs that align with the ResMed mission 
of advancing innovative technologies in sleep and respiratory medicine. Support is typically provided in the manner of funding and/or devices, depending on the type of research.


Grants will be considered to support independent medical research with scientific merit, provided that the following guidelines are met:

• The research proposal addresses a legitimate scientific need that is identified and documented in advance (ResMed does not consider requests for unrestricted grants).

• The principal investigator must have the appropriate education, training and experience to successfully conduct and complete the proposed research, with the highest ethical standards. The research proposal must include a detailed, line-item budget that is based on fair market value.

• If a research proposal is accepted, a written agreement with well-defined goals, objectives and milestones must be executed by ResMed and the investigator(s) prior to commencement of the project.

Checklist for Proposal Submission

A concept proposal should contain an adequate amount of information in order for ResMed to determine interest in receiving a full submission.  You may also consider submitting a full submission alone.

The full submission checklist is provided to ensure that proposals contain all the necessary documentation required for evaluation. A full proposal submission must contain enough detail about the research study and the grant request to enable ResMed to make a final evaluation regarding support.  

You can find additional details on ResMed’s support for Investigator Initiated Trials here.

Need more information?

For further information about research grants, please contact the Office of Medical Affairs at